ArticlePathogens (Basel, Switzerland)2025
Coprological and Molecular Analyses of Ruminant Farms in Québec, Canada, Show a Variable Efficacy of Ivermectin Against Gastro-Intestinal Nematodes.
Article in Pathogens (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Gastro-intestinal nematodes (GINs) are still of great concern in grazing ruminants, such as camelids, ovines and caprines, affecting animal health and productivity. This is mainly due to the development of anthelmintic resistance (AR) to the compounds used long term, without much evaluation on their efficacy, including ivermectin (IVM), the most used anthelmintic drug in livestock. The aims of this study were to determine the efficacy of IVM and identify which GIN species are affecting different ruminant farms in Quebec (QC), Canada. Firstly, we collected fecal samples from six farms with different ruminant species (camelids, goats and sheep) before and after IVM treatment when applicable, analyzing them by Fecal Egg Count (FEC) and further assessments on IVM efficacy through the Fecal Egg Count Reduction Test (FECRT). In addition, molecular analyses were conducted using PCR, targeting the ITS-2 and COX-1 genes to identify GIN species. FECRT was applied only for three farms, showing that variable results with optimal efficacy (ranging from 95.5-100%) were obtained in only one farm, whereas on the other two farms, FECRT exhibited reduced efficacy, suggesting the development of IVM resistance. Among the GIN species found,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.